13th Jun 2005 12:44
New Data Analysis Shows Patients With Diabetes Taking Pfizer's Lipitor(R) Experienced Major Reductions in Heart Attack and Stroke Findings from five-year study show high doses of Lipitor (atorvastatin calcium) provide additional cardiovascular benefits SAN DIEGO, June 13 -- Data presented today at the annual meeting of the American Diabetes Association show that patients with diabetes and coronary heart disease (CHD) who took Pfizer Inc's cholesterol-lowering medicine Lipitor and lowered their cholesterol to well below recommended levels experienced significantly fewer heart attacks and strokes than those who lowered their cholesterol to achieve recommended levels. The findings are from a post-hoc analysis that involved 1,500 people with heart disease and diabetes and an LDL, or "bad" cholesterol level of PFIZER INCRelated Shares:
PFZ.L